The shift toward value-based health care has created an ever-growing need for technology companies that apply artificial intelligence, or machine-learning-enabled algorithms, to large sets of data and extract valuable information that can be used by companies and providers to create better outcomes.
One of these companies, New York-based startup Prognos, formerly known as Medivo, last November raised $20.5m in Series C funding to use their AI capabilities to help insurers predict diseases,...
Since the company was founded in 2010 as Medivo, before changing its name to Prognos in 2017, it has raised a total of $42m. The funding was used to build...